Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein (Q40735688)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 1, 1992
edit
Language Label Description Also known as
English
Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein
scientific article published on April 1, 1992

    Statements

    Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein (English)
    1 April 1992
    187
    480-491

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit